Home > Insider Trading > Filing (0001209191-14-013508)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
875320	Vertex Pharmaceuticals Inc / Ma	VRTX	Pharmaceutical Preparations (2834)	043039129

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1197036	I Bruce Sachs	C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2014-02-20	1,300	$82.51	36,910	No	4	S	Direct
Common Stock	Disposition	2014-02-20	3,800	$83.65	33,110	No	4	S	Direct
Common Stock	Disposition	2014-02-20	3,200	$84.13	29,910	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

Transaction made pursuant to Mr. Sachs' company approved trading plan under Rule 10b5-1.
Open market sales reported on this line occurred at a weighted average price of $82.51 (range $82.00 to $82.99).
Mr. Sachs undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
Open market sales reported on this line occurred at a weighted average price of $83.65 (range $83.16 to $83.99).
Open market sales reported on this line occurred at a weighted average price of $84.13 (range $84.02 to $84.35).